Linde plc (LIN.DE)
Woking, GB
Linde plc is a global industrial gas and engineering firm with extensive operations across North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. The company provides a broad range of gases, including atmospheric types such as oxygen, nitrogen, argon, and various rare gases, as well as process gases like carbon dioxide, helium, hydrogen, specialized electronic gases, and acetylene. Beyond gas supply, Linde is also a prominent engineering contractor, designing and building comprehensive, operational process plants for both external customers and its own gas production facilities. These plants encompass applications such as olefin, natural gas, air separation, hydrogen, and synthesis gas. Its services and products cater to a multitude of industries, including healthcare, energy, manufacturing, food and beverage (including carbonation), fiber-optics, steelmaking, aerospace, chemicals, and water treatment. Founded in 1879, Linde plc is headquartered in Woking, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.28% | -0.60% | +0.00% | +7.11% | +16.20% | +16.32% | +4.55% | +25.97% | +74.92% | +462.93% | +1,171.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+3.0% Q1'26: +7.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+7.3% Q1'26: +12.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+19.4% Q1'26: +10.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+26.9% ★ Q1'26: +28.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+11.6% ★ Q1'26: +12.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.1% ★ Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.09× Q1'26: 1.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 24 Rev. Ana. 1 EPS Ana. |
Dec 2027 24 Rev. Ana. 1 EPS Ana. |
Dec 2028 11 Rev. Ana. 1 EPS Ana. |
Dec 2029 23 Rev. Ana. 1 EPS Ana. |
Dec 2030 15 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
11.25B
est: 11.45B (-1.7%)
|
11.22B
est: 11.38B (-1.3%)
|
11.93B
est: 12.13B (-1.7%)
|
12.27B
est: 12.52B (-2.0%)
|
10.78B
est: 9.97B (+8.1%)
|
10.53B
est: 9.99B (+5.4%)
|
11.44B
est: 9.42B (+21.4%)
|
14.84B
est: 24.33B (-39.0%)
|
28.23B
est: 25.09B (+12.5%)
|
27.24B
est: 22.09B (+23.3%)
|
30.79B
est: 26.69B (+15.4%)
|
33.36B
est: 31.69B (+5.3%)
|
32.85B
est: 29.67B (+10.7%)
|
33.01B
est: 33.35B (-1.0%)
|
33.99B
est: 33.87B (+0.3%)
|
35.24B
35.24B – 35.54B
+4.0% YoY
|
37.01B
37.01B – 37.62B
+5.0% YoY
|
39.18B
39.18B – 39.66B
+5.8% YoY
|
42.80B
42.80B – 43.33B
+9.2% YoY
|
43.34B
43.34B – 43.88B
+1.3% YoY
|
| EBITDA |
3.45B
est: 3.09B (+11.5%)
|
3.47B
est: 3.14B (+10.7%)
|
3.69B
est: 3.33B (+10.7%)
|
3.71B
est: 3.44B (+7.9%)
|
3.27B
est: 2.94B (+11.2%)
|
3.38B
est: 3.00B (+12.6%)
|
3.75B
est: 3.20B (+17.1%)
|
7.12B
est: 7.29B (-2.3%)
|
8.10B
est: 6.44B (+25.8%)
|
8.12B
est: 7.17B (+13.4%)
|
9.89B
est: 7.60B (+30.2%)
|
9.94B
est: 7.92B (+25.6%)
|
12.29B
est: 8.21B (+49.8%)
|
12.92B
est: 12.20B (+5.9%)
|
12.92B
est: 16.01B (-19.3%)
|
16.66B
16.66B – 16.80B
+4.0% YoY
|
17.50B
17.50B – 17.78B
+5.0% YoY
|
18.52B
18.52B – 18.75B
+5.8% YoY
|
20.23B
20.23B – 20.48B
+9.2% YoY
|
20.49B
20.49B – 20.75B
+1.3% YoY
|
| EBIT |
2.44B
est: 2.33B (+4.9%)
|
2.47B
est: 2.45B (+0.7%)
|
2.58B
est: 2.60B (-0.8%)
|
2.54B
est: 2.71B (-6.3%)
|
2.16B
est: 2.29B (-5.7%)
|
2.26B
est: 2.24B (+0.5%)
|
2.57B
est: 2.41B (+6.4%)
|
5.29B
est: 6.14B (-13.9%)
|
3.43B
est: 5.20B (-34.1%)
|
3.50B
est: 2.77B (+26.4%)
|
5.26B
est: 2.93B (+79.2%)
|
5.74B
est: 3.06B (+87.6%)
|
8.48B
est: 3.17B (+167.4%)
|
9.14B
est: 13.54B (-32.5%)
|
9.15B
est: 13.49B (-32.2%)
|
14.04B
14.04B – 14.16B
+4.0% YoY
|
14.74B
14.74B – 14.98B
+5.0% YoY
|
15.61B
15.61B – 15.80B
+5.8% YoY
|
17.05B
17.05B – 17.26B
+9.2% YoY
|
17.27B
17.27B – 17.48B
+1.3% YoY
|
| Net Income |
1.67B
est: 1.34B (+25.0%)
|
1.69B
est: 1.66B (+1.9%)
|
1.76B
est: 1.80B (-2.7%)
|
1.69B
est: 1.81B (-6.5%)
|
1.55B
est: 1.49B (+3.9%)
|
1.50B
est: 1.50B (+0.3%)
|
1.25B
est: 1.61B (-22.6%)
|
4.38B
est: 3.13B (+39.9%)
|
2.29B
est: 4.34B (-47.4%)
|
2.50B
est: 2.16B (+16.0%)
|
3.83B
est: 2.29B (+67.4%)
|
4.15B
est: 2.38B (+74.2%)
|
6.20B
est: 2.47B (+151.0%)
|
6.57B
est: 7.37B (-10.9%)
|
6.90B
est: 7.76B (-11.1%)
|
8.30B
8.30B – 8.43B
+6.9% YoY
|
9.08B
9.08B – 9.23B
+9.5% YoY
|
10.00B
10.00B – 10.16B
+10.1% YoY
|
11.87B
11.87B – 12.07B
+18.7% YoY
|
11.61B
11.61B – 11.80B
-2.2% YoY
|
| SGA |
1.24B
est: 1.34B (-7.4%)
|
1.27B
est: 1.23B (+3.2%)
|
1.29B
est: 1.35B (-4.5%)
|
1.31B
est: 1.39B (-6.1%)
|
1.15B
est: 1.15B (+0.2%)
|
1.15B
est: 1.11B (+2.8%)
|
1.21B
est: 1.23B (-1.9%)
|
1.63B
est: 3.03B (-46.3%)
|
3.46B
est: 1.61B (+114.1%)
|
3.19B
est: 3.26B (-2.1%)
|
3.19B
est: 3.46B (-7.8%)
|
3.11B
est: 3.60B (-13.8%)
|
3.30B
est: 3.74B (-11.8%)
|
3.34B
est: 3.39B (-1.6%)
|
3.43B
est: 3.38B (+1.5%)
|
3.52B
3.52B – 3.55B
+4.0% YoY
|
3.69B
3.69B – 3.75B
+5.0% YoY
|
3.91B
3.91B – 3.96B
+5.8% YoY
|
4.27B
4.27B – 4.32B
+9.2% YoY
|
4.33B
4.33B – 4.38B
+1.3% YoY
|
| EPS |
5.53
est: 7.16 (-22.7%)
|
5.67
est: 7.26 (-21.8%)
|
5.94
est: 7.95 (-25.3%)
|
5.79
est: 8.22 (-29.5%)
|
5.39
est: 5.33 (+1.0%)
|
5.25
est: 5.20 (+1.0%)
|
4.36
est: 4.84 (-9.9%)
|
13.26
est: 4.95 (+167.6%)
|
4.22
est: 6.50 (-35.1%)
|
4.75
est: 6.62 (-28.2%)
|
7.40
est: 9.33 (-20.7%)
|
8.30
est: 11.25 (-26.2%)
|
12.70
est: 12.77 (-0.6%)
|
13.71
est: 15.47 (-11.4%)
|
14.69
est: 16.43 (-10.6%)
|
17.57
17.57 – 17.85
+6.9% YoY
|
19.24
19.24 – 19.55
+9.5% YoY
|
21.18
21.18 – 21.52
+10.1% YoY
|
25.15
25.15 – 25.55
+18.7% YoY
|
24.60
24.60 – 25.00
-2.2% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-04 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-04-24 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-04-17 | Seaport Global | Buy | Buy | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sanjiv Lamba | Chief Executive Officer & Director | 6M | male |
| John Mathew Panikar | Executive Vice President of APAC | 4M | male |
| Matthew J. White | Executive Vice President & Chief Financial Officer | 3M | male |
| Sean F. Durbin | Executive Vice President of EMEA | 3M | male |
| Guillermo Bichara | Executive Vice President & Chief Legal Officer | — | male |
| Sandeep Sen | Chief Information Officer | — | — |
| Luiz Oliveira | Vice President of Operations, Excellence & Productivity | — | male |
| John van der Velden | Senior Vice President of Engineering Sales & Technology | — | — |
| Juan Pelaez | Vice President of Investor Relations | — | male |
| Kelcey E. Hoyt | Vice President & Chief Accounting Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LIN.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
